why choose us

First received: February 13, 2023

Clinical Trial: Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult Participants

Study Status: Completed

Recruit Status: RECRUITING

Condition: Generalized Anxiety Disorder (GAD)

Study Type: INTERVENTIONAL


Official Title: Generalized Anxiety Disorder (GAD): A First-in-Human Single Ascending Dose and Food Effect Study of ABBV-932 in Healthy Adult Subjects

Brief Summary: The main objective of this study is to assess pharmacokinetics, safety, and tolerability of ABBV-932 in healthy adult participants.

Read more